Literature DB >> 12965913

Contribution of serum immunoglobulin transudate to the antibody immune status of murine intestinal secretions: influence of different sampling procedures.

Barbara Meckelein1, Dörthe Externest, M Alexander Schmidt, Andreas Frey.   

Abstract

Serum immunoglobulin transudation into the murine gut after intragastric immunization with the model antigen ovalbumin and cholera toxin adjuvant was investigated with regard to the mucosal sampling technique applied. The levels of serum-derived immunoglobulin A (IgA) turned out to be lowest in feces, intermediate in gut lavage fluid specimens, and highest in filter wick-collected samples. However, these levels did not exceed 2% of total and specific IgA in any mucosal sample type, except after the administration of very high antigen doses (> or =1 mg of antigen per g of body weight), when transudation rates of up to 31% could be measured in filter wick-collected samples from individual animals. Luminal IgG was plasma transudate and/or bile borne and appeared to be reabsorbed at the mucosa to some extent.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12965913      PMCID: PMC193900          DOI: 10.1128/cdli.10.5.831-834.2003

Source DB:  PubMed          Journal:  Clin Diagn Lab Immunol        ISSN: 1071-412X


  13 in total

1.  Correlations between antibody immune responses at different mucosal effector sites are controlled by antigen type and dosage.

Authors:  D Externest; B Meckelein; M A Schmidt; A Frey
Journal:  Infect Immun       Date:  2000-07       Impact factor: 3.441

2.  Polymeric IgA is superior to monomeric IgA and IgG carrying the same variable domain in preventing Clostridium difficile toxin A damaging of T84 monolayers.

Authors:  H Stubbe; J Berdoz; J P Kraehenbuhl; B Corthésy
Journal:  J Immunol       Date:  2000-02-15       Impact factor: 5.422

Review 3.  Evaluation of events occurring at mucosal surfaces: techniques used to collect and analyze mucosal secretions and cells.

Authors:  Bruno Guy
Journal:  Clin Diagn Lab Immunol       Date:  2002-07

4.  Secretory component: a new role in secretory IgA-mediated immune exclusion in vivo.

Authors:  Armelle Phalipon; Ana Cardona; Jean Pierre Kraehenbuhl; Léna Edelman; Philippe J Sansonetti; Blaise Corthésy
Journal:  Immunity       Date:  2002-07       Impact factor: 31.745

5.  Antibodies and antibody-secreting cells in the female genital tract after vaginal or intranasal immunization with cholera toxin B subunit or conjugates.

Authors:  E L Johansson; C Rask; M Fredriksson; K Eriksson; C Czerkinsky; J Holmgren
Journal:  Infect Immun       Date:  1998-02       Impact factor: 3.441

6.  A stable and highly sensitive 3,3',5,5'-tetramethylbenzidine-based substrate reagent for enzyme-linked immunosorbent assays.

Authors:  A Frey; B Meckelein; D Externest; M A Schmidt
Journal:  J Immunol Methods       Date:  2000-01-13       Impact factor: 2.303

7.  Lack of association of secretory component with IgA in J chain-deficient mice.

Authors:  B A Hendrickson; L Rindisbacher; B Corthesy; D Kendall; D A Waltz; M R Neutra; J G Seidman
Journal:  J Immunol       Date:  1996-07-15       Impact factor: 5.422

8.  Secretion of immunoglobulins and plasma proteins from the jejunal mucosa. Transport rate and origin of polymeric immunoglobulin A.

Authors:  P P Jonard; J C Rambaud; C Dive; J P Vaerman; A Galian; D L Delacroix
Journal:  J Clin Invest       Date:  1984-08       Impact factor: 14.808

9.  Induction of specific immunoglobulin A in the small intestine, colon-rectum, and vagina measured by a new method for collection of secretions from local mucosal surfaces.

Authors:  B Haneberg; D Kendall; H M Amerongen; F M Apter; J P Kraehenbuhl; M R Neutra
Journal:  Infect Immun       Date:  1994-01       Impact factor: 3.441

10.  Absence of epithelial immunoglobulin A transport, with increased mucosal leakiness, in polymeric immunoglobulin receptor/secretory component-deficient mice.

Authors:  F E Johansen; M Pekna; I N Norderhaug; B Haneberg; M A Hietala; P Krajci; C Betsholtz; P Brandtzaeg
Journal:  J Exp Med       Date:  1999-10-04       Impact factor: 14.307

View more
  5 in total

1.  Mucosal and systemic adjuvant activity of alphavirus replicon particles.

Authors:  Joseph M Thompson; Alan C Whitmore; Jennifer L Konopka; Martha L Collier; Erin M B Richmond; Nancy L Davis; Herman F Staats; Robert E Johnston
Journal:  Proc Natl Acad Sci U S A       Date:  2006-02-27       Impact factor: 11.205

2.  Vaccine-induced intestinal immunity to ricin toxin in the absence of secretory IgA.

Authors:  Lori M Neal; Elizabeth A McCarthy; Carolyn R Morris; Nicholas J Mantis
Journal:  Vaccine       Date:  2010-11-27       Impact factor: 3.641

3.  Induction of mucosal and systemic antibody and T-cell responses following prime-boost immunization with novel adjuvanted human immunodeficiency virus-1-vaccine formulations.

Authors:  Anthony D Cristillo; Maria Grazia Ferrari; Lauren Hudacik; Brad Lewis; Lindsey Galmin; Britany Bowen; DeVon Thompson; Nikolai Petrovsky; Phillip Markham; Ranajit Pal
Journal:  J Gen Virol       Date:  2011-01       Impact factor: 3.891

4.  A universal polysaccharide conjugated vaccine against O111 E. coli.

Authors:  Gabrielle R Andrade; Roger R C New; Osvaldo A Sant'Anna; Neil A Williams; Rosely C B Alves; Daniel C Pimenta; Hugo Vigerelli; Bruna S Melo; Letícia B Rocha; Roxane M F Piazza; Lucia Mendonça-Previato; Marta O Domingos
Journal:  Hum Vaccin Immunother       Date:  2014-11-21       Impact factor: 3.452

5.  E2 multimeric scaffold for vaccine formulation: immune response by intranasal delivery and transcriptome profile of E2-pulsed dendritic cells.

Authors:  Maria Trovato; Francesco Maurano; Luciana D'Apice; Valerio Costa; Rossella Sartorius; Fausta Cuccaro; Sean P McBurney; Shelly J Krebs; Antonella Prisco; Alfredo Ciccodicola; Mauro Rossi; Nancy L Haigwood; Piergiuseppe De Berardinis
Journal:  BMC Microbiol       Date:  2016-07-16       Impact factor: 3.605

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.